Cargando…
R-Flurbiprofen Traps Prostaglandins within Cells by Inhibition of Multidrug Resistance-Associated Protein-4
R-flurbiprofen is the non-COX-inhibiting enantiomer of flurbiprofen and is not converted to S-flurbiprofen in human cells. Nevertheless, it reduces extracellular prostaglandin E(2) (PGE(2)) in cancer or immune cell cultures and human extracellular fluid. Here, we show that R-flurbiprofen acts throug...
Autores principales: | Wobst, Ivonne, Ebert, Lisa, Birod, Kerstin, Wegner, Marthe-Susanna, Hoffmann, Marika, Thomas, Dominique, Angioni, Carlo, Parnham, Michael J., Steinhilber, Dieter, Tegeder, Irmgard, Geisslinger, Gerd, Grösch, Sabine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297703/ https://www.ncbi.nlm.nih.gov/pubmed/28042832 http://dx.doi.org/10.3390/ijms18010068 |
Ejemplares similares
-
R-flurbiprofen attenuates experimental autoimmune encephalomyelitis in mice
por: Schmitz, Katja, et al.
Publicado: (2014) -
The UDP-glucose ceramide glycosyltransferase (UGCG) and the link to multidrug resistance protein 1 (MDR1)
por: Wegner, Marthe-Susanna, et al.
Publicado: (2018) -
Inhibitors of Human 5-Lipoxygenase Potently Interfere With Prostaglandin Transport
por: Kahnt, Astrid S., et al.
Publicado: (2022) -
R-Flurbiprofen Reduces Neuropathic Pain in Rodents by Restoring Endogenous Cannabinoids
por: Bishay, Philipp, et al.
Publicado: (2010) -
Monoclonal Antibodies in Preclinical EAE Models of Multiple Sclerosis: A Systematic Review
por: Schmitz, Katja, et al.
Publicado: (2017)